Skip to content Skip to sidebar Skip to footer
Alterity Therapeutics
Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m
Alterity Therapeutics (ASX:ATH) hit the jackpot last week. Any clinical-stage biotech achieving a positive Phase 2 outcome is good news, because it depicts that the company's drug is not just safe, but that it works too. But while some companies (like Paradigm (ASX:PAR)) are going after markets with existing drugs that need replacement, Alterity is…
will Star Entertainment stay afloat
How much longer will Star Entertainment stay afloat? How big of a reprieve will the $60m fire sale of its events centre be?
How much longer will Star Entertainment stay afloat? By now it seems a fait accompli that Star Entertainment (ASX:SGR) will collapse - it is question of when and not if. It had a cash balance of $79m as at the close of CY24, is burning through $50m every month, its debtors have had a gutful…
iron ore prices in 2025
Analysts aren’t optimistic about iron ore prices in 2025, will they be right and what will it mean for iron ore stocks?
In which direction will iron ore prices in 2025 go? Chinese trade data would suggest upwards, and indeed prices jumped 7% last week to surpass US$104.15. If Beijing unleashes new stimulus and it has the desired effect, the prospect of iron ore prices making a return to 2021 boom levels wouldn't be completely impossible to…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here